Advancing Safe Medications for Moms and Babies Act of 2026
To implement certain recommendations to promote the inclusion of pregnant and lactating women in clinical research, and for other purposes.
HB8651, the "Advancing Safe Medications for Moms and Babies Act of 2026," aims to enhance the safety of medications for pregnant and breastfeeding women by encouraging their inclusion in clinical research. This bill proposes to implement recommendations that ensure these women receive medications that are both safe and effective for them and their babies.
This legislation will affect pregnant and lactating women, healthcare providers, pharmaceutical companies, and researchers. By including these women in clinical trials, the bill hopes to create better-informed guidelines and safer medication options for them.
As of the last update on May 4, 2026, HB8651 was introduced in the House and referred to the House Committee on Energy and Commerce. This means the bill is currently under review by committee members who will assess its potential impacts and make recommendations for further action. Key actions so far include its introduction and referral, with ongoing committee review expected to follow.
